Cary Vance

Cary Vance

Interim Chief Executive OfficeratAVITA Medical· In proxies 2023–2025

Pay in FY2024AVITA Medical stock -6.7% the same year

Cary Vance was paid $0 in FY2024 (Dec). AVITA Medical stock fell 6.7% that year.

Pay$100 in the stock at the end of FY23 → $93
Pay is from the Summary Compensation Table of each AVITA Medical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AVITA MedicalPublic company · 3 yr
    • Interim Chief Executive Officer2023 – Present · 3 yrStock in role +148%

Roles come from the proxy statements of each company.

Boards1

  • AVITA MedicalDirector · 0 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?